These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15704575)

  • 1. [Long-term usefulness of alendronate confirmed. Bones still benefit even after 10 years].
    MMW Fortschr Med; 2005 Jan; 147(1-2):53. PubMed ID: 15704575
    [No Abstract]   [Full Text] [Related]  

  • 2. [To increase bone density faster and stronger].
    MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589
    [No Abstract]   [Full Text] [Related]  

  • 3. [FACT study: benefits of alendronate].
    MMW Fortschr Med; 2005 Jan; 147(1-2):52-3. PubMed ID: 15704574
    [No Abstract]   [Full Text] [Related]  

  • 4. Ten years of alendronate treatment for osteoporosis in postmenopausal women.
    Ott SM
    N Engl J Med; 2004 Jul; 351(2):190-2; author reply 190-2. PubMed ID: 15250064
    [No Abstract]   [Full Text] [Related]  

  • 5. Do not use bisphosphonate therapy indefinitely for fracture prevention.
    Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].
    Praxis (Bern 1994); 2004 Sep; 93(36):1454. PubMed ID: 15487859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alendronate also for women without established osteoporosis?].
    Klovning A; Norheim OF
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1347-51. PubMed ID: 10868100
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long term effects of raloxifen on the bones].
    Eiken PA
    Ugeskr Laeger; 2008 Jan; 170(4):224-6. PubMed ID: 18282451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term insurance for the bones. Effective and safe over 7 years].
    MMW Fortschr Med; 2002 Jun; 144(25):52-3. PubMed ID: 12141293
    [No Abstract]   [Full Text] [Related]  

  • 11. [An advantage for compliance: alendronate once weekly].
    MMW Fortschr Med; 2005 Dec; 147(49-50):75. PubMed ID: 16401017
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
    Choi HJ; Im JA; Kim SH
    Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological and clinical profile of once weekly alendronate for the treatment of osteoporosis (Fosamac 35 mg/Bonalon 35 mg)].
    Uchida S; Azuma Y; Taniguchi T; Arizono H; Shimizu T; Okaniwa M; Nakamura K; Ohta T
    Nihon Yakurigaku Zasshi; 2007 Oct; 130(4):305-12. PubMed ID: 17938517
    [No Abstract]   [Full Text] [Related]  

  • 15. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern osteoporosis therapy. Only once weekly against osteoporosis].
    MMW Fortschr Med; 2001 Jul; 143(28-29):52-3. PubMed ID: 11499150
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten years of alendronate treatment for osteoporosis in postmenopausal women.
    Bjarnason NH
    N Engl J Med; 2004 Jul; 351(2):190-2; author reply 190-2. PubMed ID: 15247362
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.
    Eviö S; Tarkkila L; Sorsa T; Furuholm J; Välimäki MJ; Ylikorkala O; Tiitinen A; Meurman JH
    Oral Dis; 2006 Mar; 12(2):187-93. PubMed ID: 16476042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.